Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高级检索
  • NOVEL INFLAMMATORY RISK MARKER...
  • 引用
  • 发送短信
  • 推荐此
  • 打印
  • 导出纪录
    • 导出到 RefWorks
    • 导出到 EndNoteWeb
    • 导出到 EndNote
  • Permanent link
NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

Show other versions (1)
书目详细资料
Main Authors: Seed, M, Betteridge, J, Caslake, M, Cooper, J, Humphries, S, Neil, A
格式: Journal article
出版: 2009
  • 持有资料
  • 实物特征
  • Other Versions (1)
  • 相似书籍
  • 职员浏览

相似书籍

  • NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
    由: Seed, M, et al.
    出版: (2009)
  • Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
    由: Neil, A, et al.
    出版: (2003)
  • Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
    由: Neil, H, et al.
    出版: (2003)
  • Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
    由: Neil, H, et al.
    出版: (2004)
  • CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
    由: Seed, M, et al.
    出版: (2011)

检索选项

  • 检索历史
  • 高级检索

查找更多

  • 浏览目录
  • 按字母顺序浏览
  • 探索频道
  • 课程储备
  • 新项目

需要帮助?

  • 检索技巧
  • 咨询台
  • 常见问题